Result of AGM

AstraZeneca PLC
27 April 2023
 

27 April 2023 17:30 BST

 

Results of Annual General Meeting held on 27 April 2023

 

AstraZeneca PLC announced the results of the voting at its Annual General Meeting (AGM) today. As proposed in the Notice of AGM, all Resolutions were decided by poll vote. Resolutions 9 - 13 were passed as special resolutions; all other resolutions were passed as ordinary resolutions.

 

 

Resolution

Votes for

% of votes cast

Votes against

% of votes cast

Votes cast in total

Total votes cast as a % of issued share capital

Votes withheld

1

To receive the Company's Accounts, the Reports of the Directors and Auditor and the Strategic Report for the year ended 31 December 2022

1,264,644,490

99.80

2,524,193

0.20

1,267,168,683

81.76

2,068,894

2

To confirm dividends

1,254,919,878

98.92

13,679,112

1.08

1,268,598,990

81.85

638,576

3

To reappoint PricewaterhouseCoopers LLP as Auditor

1,260,792,714

99.39

7,718,080

0.61

1,268,510,794

81.85

726,500

4

To authorise the Directors to agree the remuneration of the Auditor

1,268,225,831

99.98

270,095

0.02

1,268,495,926

81.85

741,641

5a

To re-elect Michel Demaré as a Director

1,241,496,328

97.88

26,829,809

2.12

1,268,326,137

81.84

911,430

5b

To re-elect Pascal Soriot as a Director

1,260,336,535

99.37

7,986,485

0.63

1,268,323,020

81.83

914,729

5c

To re-elect Aradhana Sarin as a Director

1,265,264,711

99.76

3,062,442

0.24

1,268,327,153

81.84

910,131

5d

To re-elect Philip Broadley as a Director

1,259,273,602

99.29

9,043,851

0.71

1,268,317,453

81.83

920,114

5e

To re-elect Euan Ashley as a Director

1,268,022,043

99.98

282,266

0.02

1,268,304,309

81.83

924,629

5f

To re-elect Deborah DiSanzo as a Director

1,267,959,577

99.97

349,778

0.03

1,268,309,355

81.83

926,746

5g

To re-elect Diana Layfield as a Director

1,268,027,536

99.98

274,653

0.02

1,268,302,189

81.83

935,378

5h

To re-elect Sheri McCoy as a Director

1,241,492,257

97.88

26,842,094

2.12

1,268,334,351

81.84

903,216

5i

To re-elect Tony Mok as a Director

1,261,574,735

99.97

322,367

0.03

1,261,897,102

81.42

7,338,922

5j

To re-elect Nazneen Rahman as a Director

1,266,284,904

99.85

1,870,104

0.15

1,268,155,008

81.82

1,082,559

5k

To re-elect Andreas Rummelt as a Director

1,268,030,928

99.98

285,793

0.02

1,268,316,721

81.83

920,846

5l

To re-elect Marcus Wallenberg as a Director

1,026,140,887

80.93

241,825,345

19.07

1,267,966,232

81.81

1,263,367

6

To approve the Annual Report on Remuneration for the year ended 31 December 2022

1,195,261,107

94.23

73,125,360

5.77

1,268,386,467

81.84

850,827

7

To authorise limited political donations

1,228,047,446

97.76

28,189,687

2.24

1,256,237,133

81.06

13,000,783

8

To authorise the Directors to allot shares

1,166,174,071

91.95

102,088,563

8.05

1,268,262,634

81.83

966,964

9

To authorise the Directors to disapply pre-emption rights

1,193,686,193

94.15

74,121,064

5.85

1,267,807,257

81.80

1,430,310

10

To authorise the Directors to further disapply pre-emption rights for acquisitions and specified capital investments

1,153,850,923

91.25

110,689,108

8.75

1,264,540,031

81.59

4,697,303

11

To authorise the Company to purchase its own shares

1,254,158,039

98.92

13,730,760

1.08

1,267,888,799

81.81

1,348,767

12

To reduce the notice period for general meetings

1,178,311,157

93.41

83,098,807

6.59

1,261,409,964

81.39

7,827,602

13

To adopt new Articles of Association of the Company  

1,258,637,857

99.26

9,327,063

0.74

1,267,964,920

81.81

1,272,646

 

A copy of the resolutions passed at the AGM (other than resolutions concerning ordinary business) has been submitted to the National Storage Mechanism for publication, and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 Issued capital

As at 25 April 2023, the number of issued shares of the Company was 1,549,856,584 ordinary shares, which was the total number of shares entitling the holders to attend and vote for or against all of the resolutions at the AGM. In accordance with the Company's Articles of Association, on a poll every member present in person or by proxy has one vote for every share held.

 

AstraZeneca

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca.

 

Contacts

For details on how to contact the Investor Relations Team, please click here. For Media contacts, click here.

 

 

Adrian Kemp
Company Secretary

AstraZeneca PLC

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

AstraZeneca (AZN)
UK 100

Latest directors dealings